Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Q5MC
|
||||
Former ID |
DIB004909
|
||||
Drug Name |
PCI-34051
|
||||
Synonyms |
PCI-34051; PCI-34259; PCI-34260; PCI-40505; PCI-43744; PCI-45159; PCI-47634; PCI-48000; PCI-48001; PCI-48002; PCI-48003; PCI-48004; PCI-48006; PCI-48007; PCI-48008; PCI-48009; PCI-48010; PCI-48011; PCI-48012; PCI-48013; PCI-48018; PCI-48036; PCI-48039; HDAC 8 inhibitors (cancer/inflammation); HDAC 8 inhibitors (cancer/inflammation), Pharmacyclics
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543663] | ||
Company |
Pharmacyclics Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C17H16N2O3
|
||||
Canonical SMILES |
n1(ccc2ccc(cc12)C(=O)NO)Cc1ccc(cc1)OC
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Histone Deacetylase 8 | Target Info | Inhibitor | [543663] | |
KEGG Pathway | Alcoholism | ||||
Viral carcinogenesis | |||||
PANTHER Pathway | Wnt signaling pathway | ||||
Pathway Interaction Database | Signaling events mediated by HDAC Class I | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.